The Chinese University of Hong Kong
Hong Kong, China
Location status: Recruiting
NCT Number: NCT07388797
Hypotheses:
We hypothesize that serum progesterone levels on the day of embryo transfer in HRT-FET cycles are positively associated with clinical pregnancy rates.
Aims:
To evaluate the relationship between serum progesterone levels on embryo transfer day and clinical pregnancy outcomes in frozen-thawed embryo transfer cycles using hormone replacement therapy (HRT).
Primary outcome:
To compare the incidence of clinical pregnancy outcome in those infertility patients undergoing frozen embryo transfer with caterized Progesterone level on the day of embryo transfer
Secondary outcomes:
Biochemical pregnancy rate. Implantation rate. Early pregnancy loss rate. Ectopic pregnancy rate.
Interested in participating?
Request Info18 year–42 year
Female
Observational
Hong Kong, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 weeks of gestation and ultrasound scanning will be performed to confirm at least one gestational sac around 1 to 3 months after FET
Rate of clinical pregnancy outcome in subjects undergoing FET
Time frame: Up to 12 weeks
Rate of biochemical pregnancy outcome in subjects undergoing FET
Time frame: Up to 12 weeks
Rate of implantation in subjects undergoing FET
Time frame: Up to 12 weeks
Rate of early pregnancy loss in subjects undergoing FET
Time frame: Up to 12 weeks
Rate of Ectopic pregnancy in subjects undergoing FET
Chinese University of Hong Kong
Other
Impact of Serum Progesterone Levels on Embryo Transfer Day on Clinical Pregnancy in Frozen-thawed Embryo Transfer Cycles Using Hormone Replacement Therapy: a Prospective Observational Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07456397
Genital Diseases, Genital Diseases, Male
Barcelona, Spain
View Trial DetailsNCT07344623
Reproductive Issues
Hong Kong, China
View Trial DetailsNCT06293235
Fertility Issues, Genital Diseases
Singapore
View Trial DetailsNCT06742437
Asthenozoospermia, Genital Diseases
Barcelona, Spain
View Trial Details